COMP <GO>
BDX vs LLY // RSI-14 & 200D SMA MOMENTUM
Becton Dickinson and Company (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: BDX 3
— LLY 12
▲ RSI-14 & 200D SMA MOMENTUM LEADER: LLY
LAST: $197.88 (-0.23%) • MKT CAP: $54.03B
rsi-technicals
64.0
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
rsi-technicals
77.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDX VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BDX | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.40% | 83.64% | -38.24 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 32.36% | -27.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 36.4x | -14.62 | BDX | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 2.30% | -0.17 | LLY | /fcf-yield <GO> |
| Operating Margin | 11.80% | 40.21% | -28.41 | LLY | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 31.90% | -24.20 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 8.20% | 45.51% | -37.31 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.21% | 0.49% | +1.72 | BDX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 9.29 | -7.07 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.77% | +0.33 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 64.0 | 77.9 | -13.87 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.51 | +0.55 | BDX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.9x | 26.3x | +3.65 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $54.03B | $1.33T | -$1.28T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BDX REV | LLY REV | BDX GROSS % | LLY GROSS % | BDX FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.84B | $65.18B | 45.4% | 83.0% | $1.12B | $16.81B |
| FY 2024 | $20.18B | $45.04B | 45.2% | 81.3% | $1.18B | $8.82B |
| FY 2023 | $19.37B | $34.12B | 44.0% | 79.3% | $790.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDX // BETA 1.06
LLY // BETA 0.51